超声造影对恶性门静脉血栓的表征
前瞻性研究评估超声造影(CEUS)鉴别良恶性门静脉血栓(PVT)的效果,纳入43例慢性肝病、肝癌可疑结节且确诊PVT的患者,以随访影像(US、CT和/或MRI,CEUS后最长6个月)为参考标准。随访显示恶性PVT 22例(51%)、良性PVT 21例(49%),CEUS与随访结果一致41例(95%),κ=0.903(p<0.0001),敏感度91%、特异度100%,表明CEUS可可靠鉴别慢性肝病背景下的良恶性门静脉血栓。
要点
- CEUS鉴别良恶性门静脉血栓与随访影像一致率95%(41/43),κ=0.903。
- CEUS诊断恶性门静脉血栓敏感度91%、特异度100%。
- 评估内容包括血管壁破坏和/或侵犯、彩色多普勒血流、脉冲多普勒血流模式及CEUS增强和血管化模式。
核心结论
- CEUS可可靠用于慢性肝病背景下鉴别良性与恶性门静脉血栓。
研究设计与样本
- 前瞻性研究,共43例慢性肝病、肝癌可疑结节且确诊PVT的患者,以CEUS后最长6个月内的随访影像(US、CT和/或MRI)为参考标准确认PVT性质。
关键影像表现/征象
- 评估PVT的血管壁破坏和/或侵犯、彩色多普勒血管化、脉冲多普勒血管化模式以及CEUS增强和血管化模式,据此将血栓分为良性或恶性。
诊断标准与关键数值
- CEUS与随访结果一致41/43例(95%),κ=0.903(p<0.0001)。
- CEUS诊断恶性PVT的敏感度91%、特异度100%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
We prospectively evaluated the effectiveness of contrast-enhanced ultrasonography (CEUS) for differentiation of benign versus malignant portal vein thrombosis (PVT). We studied a total of 43 patients with chronic liver disease, hepatocellular carcinoma-suggestive nodules and confirmed PVT, in whom the nature of the PVT was confirmed by follow-up imaging (US, computed tomography and/or magnetic resonance imaging) performed up to 6 mo after CEUS. PVT was assessed by US, Doppler US and CEUS with respect to vessel wall disruption and/or invasion, color Doppler vascularization, pulsed Doppler vascularization pattern and CEUS enhancement and vascularization pattern, and thrombi were classified as benign or malignant based on these findings. Follow-up studies revealed malignant PVT in 22 of the 43 patients (51%) and benign PVT in 21 patients (49%). CEUS findings were consistent with follow-up studies in 41 of the 43 patients (95%), with κ = 0.903 (p < 0.0001), sensitivity = 91% and specificity = 100%, indicating that CEUS can be confidently used to differentiate benign from malignant portal vein thrombosis in the setting of chronic liver disease.
引用
- Chammas MC, Oliveira AC, D Ávilla MJ, et al. Characterization of Malignant Portal Vein Thrombosis with Contrast-Enhanced Ultrasonography. Ultrasound Med Biol. 2018. PMID: 30366607. doi:10.1016/j.ultrasmedbio.2018.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。